000			01799 a2200529 4500
005			20250516002335.0
264		0	_c20101008
008			201010s 0 0 eng d
022			_a1526-632X
024	7		_a10.1212/WNL.0b013e3181f25f06 _2doi
040			_aNLM _beng _cNLM
100	1		_avan Elderen, S G C
245	0	0	_aProgression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up. _h[electronic resource]
260			_bNeurology _cSep 2010
300			_a997-1002 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAtrophy
650	0	4	_aBrain _xpathology
650	0	4	_aCognition Disorders _xetiology
650	0	4	_aDiabetes Complications _xpathology
650	0	4	_aDiabetes Mellitus, Type 2 _xpathology
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use
650	0	4	_aHyperglycemia _xcomplications
650	0	4	_aHypoglycemic Agents _xadverse effects
650	0	4	_aInsulin _xadverse effects
650	0	4	_aLinear Models
650	0	4	_aMagnetic Resonance Imaging
650	0	4	_aMale
650	0	4	_aNeuropsychological Tests
650	0	4	_aPravastatin _xtherapeutic use
700	1		_ade Roos, A
700	1		_ade Craen, A J M
700	1		_aWestendorp, R G J
700	1		_aBlauw, G J
700	1		_aJukema, J W
700	1		_aBollen, E L E M
700	1		_aMiddelkoop, H A M
700	1		_avan Buchem, M A
700	1		_avan der Grond, J
773	0		_tNeurology _gvol. 75 _gno. 11 _gp. 997-1002
856	4	0	_uhttps://doi.org/10.1212/WNL.0b013e3181f25f06 _zAvailable from publisher's website
999			_c20168842 _d20168842